Fundz

Beta Bionics raised $60M in a Series E funding round led by Wellington Management to support the commercialization of the iLet bionic pancreas.

PUBLIC · BBNXNov 14, 2024

Amount Raised

$60 Million

Round Type

Series E

IrvineBiotechnologyHealthcare

Investors

Marshall WacePerceptive AdvisorsRTW InvestmentsSands CapitalSoleus CapitalOmega FundsEventide Asset Management, LLCWellington Management

Description

Beta Bionics has closed a Series E preferred stock financing round worth a total of $60 million. The funding will support the expanded commercialization of its iLet bionic pancreas and product pipeline development.

Quick answer

Beta Bionics raised $60 Million in a Series E round, dated November 14, 2024. Investors: Marshall Wace, Perceptive Advisors, RTW Investments, Sands Capital, Soleus Capital, Omega Funds, Eventide Asset Management, LLC and Wellington Management. Beta Bionics is based in Irvine, California, United States.

How much did Beta Bionics raise?
Beta Bionics raised $60 Million in a Series E round on November 14, 2024.
Who invested in Beta Bionics?
Marshall Wace, Perceptive Advisors, RTW Investments, Sands Capital, Soleus Capital, Omega Funds, Eventide Asset Management, LLC and Wellington Management are named as investors in this round.
What does Beta Bionics do?
Beta Bionics is a commercial stage medical technology company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with..
Where is Beta Bionics based and how big is it?
Beta Bionics is based in Irvine, California, United States. Fundz records about 455 employees.
Who are the decision-makers at Beta Bionics?
Fundz holds 2 contacts at Beta Bionics, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as Beta Bionics that raised within 45 days of this round, from Fundz verified event records.

  • Novel Microdevices raised $567K (Seed) on December 27, 2024.
  • Phio Pharmaceuticals raised $30K (Seed) on December 24, 2024.
  • Lipella Pharmaceuticals raised $2.6M (Seed) on December 23, 2024.
  • Anebulo Pharmaceuticals raised $15M on December 22, 2024.
  • Phio Pharmaceuticals raised $55K (Seed) on December 20, 2024.
  • Alessa Therapeutics raised $15M (Seed) on December 19, 2024.

Who to call at Beta Bionics, and when

A new round usually means Beta Bionics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Beta Bionics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Beta Bionics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Beta Bionics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Beta Bionics

Location

11 Hughes

Irvine, California, United States

About

Beta Bionics is a commercial stage medical technology company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWDs) by utilizing advanced adaptive algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared autonomous insulin delivery device in the market and offers the potential to substantially improve overall outcomes across broad populations of PWDs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Beta Bionics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsKevin M., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Beta Bionics's next move

See what Strategic adds

Beta Bionics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.